The MIP European Life Sciences Forum 2018 returned for it's second year at the Le Méridien Piccadilly, London on 24th April. The life sciences industry is one of the most complex, contentious and rapidly developing fields. Attendees participated in identifying key challenges faced by life sciences companies. The programme addresses major issues at hand and encouraged participation and debate on all of the pertinent topics such as: Doctrine of equivalents and the impact of the decision across your European portfolio; application of issues surrounding the use of Arrow declarations and; patent protection strategies involving divisionals. Not only did attendees have the opportunity to learn about the most significant developments in the global patent landscape over 2017-2018 but also had the fantastic opportunity to network with peers over coffee and lunch. Download the brochure here Who attended?
Delegates were able to:
REGISTRATION & ENQUIRIES Kevin Pragas +44 (0) 207 779 8938 firstname.lastname@example.org SPEAKING ENQUIRIES Natalie Canter +44 (0) 207 779 8730 email@example.com SPONSORSHIP ENQUIRIES Melanie Petch +44 (0) 207 779 8836 firstname.lastname@example.org
Stay of injunction in public interest: Edwards Lifesciences v Boston Scientific https://t.co/0TclM1zJaU
RT @titorendas: CJEU judgment in Louboutin red sole case to be delivered on June 12. Will the Court follow AG Szpunar's Opinion (available…
RT @ChrisCarani: Apple awarded $533m for design infrgment and $5m for utility infrgment. 2 certainties: appeal and more attention to design…
Technology alters the anti-counterfeiting landscape
Ellie Mertens reveals evolving technologies are changing the counterfeiting game on both sides, as a tool for both prevention and evasion
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2018 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International